MedDataX Logo

Research on Innovative Diagnosis and Treatment System of Syndrome Differentiation of Zang-fu Viscera and Effectiveness Evaluation Based on Inter-Arm Blood Pressure Measured Simultaneously

NCT ID: NCT05666531

Last Updated: 2022-12-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

750 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-01-01

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

By combining the measurement of blood pressure in both arms with the information of the four diagnoses of TCM, we try to form a diagnostic model of "five diagnoses combined with ginseng" based on TCM Zang-fu syndrome differentiation. It can further objectify and visualize the fuzzy four diagnostic indicators of TCM. In order to solve the problem of data differentiation of TCM four diagnoses, and optimize the five diagnoses of TCM conjunctive index, explore the establishment of TCM intelligent diagnosis and treatment and contact evaluation computer system

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Insomnia Chronic Gastritis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Blood pressure in both arms syndrome differentiation liver-spleen disharmony efficacy evaluation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy people

The physical examination ruled out the disease

No interventions assigned to this group

Chronic gastritis

The endoscopic diagnosis is consistent with chronic gastritis or self-reported stomachache

No interventions assigned to this group

Insomnia

The Pittsburgh Sleep Quality Index Scale was measured and assessed as meeting a diagnosis of insomnia disorder or self-reported insomnia for more than three months

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients were treated with epigastric pain and / or insomnia, which met the above diagnostic criteria for diseases, liver and spleen;
* diagnostic criteria for diseases, liver and spleen;
* Age 18-65 years old;
* It can combine mild and moderate depression, anxiety Sign the informed consent form.


* PSQI \< 5 points;
* No hypertension, diabetes, hyperlipidemia, coronary heart disease and other underlying diseases;
* No depression, anxiety, malignant tumor, syphilis, HIV and other infectious diseases;
* Over 18 years of age;
* Volunteer to participate in this study, cooperate with the measurement of blood pressure in both arms, and sign the informed consent.

Exclusion Criteria

* Patients with insomnia disorder caused by uneffectively controlled or serious diseases, such as malignant tumor, persistent pain, cardiovascular and cerebrovascular diseases, endocrine diseases, etc.;
* patients with severe depression and mental illness;
* Pregnant and lactation patients.


* sleep apnea syndrome or restless leg syndrome and other sleep disorders;
* Pregnant and lactation;
* Abnormal symptoms and abnormal tongue pulse occur in the body, such as facial acne, dysmenorrhea, thick and greasy tongue coating, loose stools, fat tongue, teeth marks and tongue.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beijing University of Chinese Medicine

OTHER

Sponsor Role collaborator

Beijing Shijitan Hospital, Capital Medical University

OTHER

Sponsor Role collaborator

Affiliated Hospital of Inner Mongolia Minzu University

UNKNOWN

Sponsor Role collaborator

Hohhot Hospital of Mongolian Medicine and TCM

UNKNOWN

Sponsor Role collaborator

Liyun He

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Liyun He

Director of TCM Clinical Efficacy Evaluation Center

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Beijing Shijitan Hospital, Capital Medical University

Beijing, , China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Liyun HE, Dr.

Role: CONTACT

Phone: 13581770875

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Liyun HE

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-1-4301

Identifier Type: -

Identifier Source: org_study_id